AZ announces results delay for key lung cancer trial
admin 12th March 2018 Uncategorised 0AstraZeneca and research arm MedImmune have announced a longer wait for survival data from a closely-watched trial testing Imfinzi in advanced lung cancer.
More: AZ announces results delay for key lung cancer trial
Source: News